
  
    
      
        Background_NNP
        The_DT arterial_NN wall_NN remodels_NNS in_IN response_NN to_TO hemodynamic_JJ
        forces_NNS imposed_VBN on_IN it_PRP by_IN blood_NN pressure_NN and_CC blood_NN flow_NN ._. The_DT
        processes_NNS of_IN arterial_NN remodeling_VBG involve_VB regulation_NN of_IN
        vascular_NN cell_NN dynamics_NNS and_CC control_NN of_IN matrix_NN synthesis_NN and_CC
        degradation_NN [_NN 1_CD ]_NN ._. Endothelial_NNP cell_NN (_( EC_NNP )_) proliferation_NN is_VBZ
        observed_VBN in_IN flow-induced_JJ arterial_NN dilation_NN [_NN 2_CD ]_NN and_CC in_IN
        vessel_NN luminal_NN expansion_NN in_IN mesenteric_JJ arterial_NN collaterals_NNS
        in_IN the_DT rat_NN [_NN 3_CD ]_NN ._. Smooth_NNP muscle_NN cells_NNS (_( SMC_NNP )_) have_VBP also_RB been_VBN
        shown_VBN to_TO proliferate_VBP in_IN the_DT vessel_NN dilatation_NN remodeling_VBG [_NN
        3_CD ]_NN ._. In_IN the_DT meantime_NN ,_, extracellular_NN matrix_NN (_( ECM_NNP )_) is_VBZ
        involved_VBN in_IN a_DT variety_NN of_IN remodeling_VBG processes_VBZ [_NN 4_CD 5_CD 6_CD 7_CD 8_CD 9_CD
        ]_NN including_VBG flow-induced_JJ arterial_NN dilation_NN [_NN 10_CD ]_NN ._. These_DT
        observations_NNS indicate_VBP that_DT cell_NN proliferation_NN and_CC ECM_NNP
        accumulation_NN are_VBP critically_RB involved_VBN in_IN vessel_NN remodeling_NN ._.
        Furthermore_RB ,_, degenerative_JJ or_CC destructive_JJ changes_NNS in_IN both_DT
        cellular_JJ and_CC extracellular_NN components_NNS of_IN the_DT vessel_NN wall_NN
        are_VBP also_RB evidenced_VBN in_IN many_JJ situations_NNS involving_VBG vessel_NN
        dilatation_NN changes_NNS ._. The_DT internal_JJ elastic_JJ lamella_NN of_IN
        arteries_NNS is_VBZ shown_VBN to_TO form_VB gaps_NNS prior_RB to_TO vessel_NN dilatation_NN
        in_IN an_DT experimental_JJ arteriovenous_JJ model_NN in_IN rabbit_NN carotid_NN
        artery_NN [_NN 2_CD ]_NN ._. Collagenase_NNP and_CC matrix_NN metalloproteinases_NNS
        (_( MMPs_NNP )_) have_VBP been_VBN observed_VBN to_TO be_VB upregulated_JJ during_IN vessel_NN
        dilation_NN either_CC in_IN flow-induced_JJ model_NN [_NN 10_CD ]_NN or_CC in_IN a_DT
        post-stenotic_JJ dilatation_NN [_NN 11_CD ]_NN ._.
        Several_JJ growth_NN factors_NNS ,_, in_IN particular_JJ TGF-β_NNP ,_, have_VBP been_VBN
        shown_VBN to_TO be_VB involved_VBN in_IN vessel_NN wall_NN remodeling_VBG with_IN respect_NN
        to_TO both_DT cellular_JJ proliferation_NN and_CC ECM_NNP accumulation_NN [_NN 12_CD 13_CD
        14_CD 15_CD ]_NN ._. Cell_NNP apoptosis_NNS has_VBZ been_VBN shown_VBN to_TO play_VB a_DT role_NN in_IN
        various_JJ remodeling_NN processes_VBZ [_NN 1_CD ]_NN ,_, including_VBG
        hypertension-induced_JJ remodeling_NN [_NN 6_CD ]_NN and_CC subnormal_NN shear_NN
        stress_NN induced_VBD endothelial_NN cell_NN apoptosis_NNS [_NN 16_CD ]_NN ._.
        Interestingly_RB ,_, TGF-β_NNP super_JJ family_NN has_VBZ been_VBN related_VBN to_TO
        apoptosis_NNS in_IN vascular_NN cells_NNS [_NN 17_CD ]_NN ._. However_RB ,_, whether_IN
        flow-induced_JJ arterial_NN dilatation_NN may_MD also_RB associated_VBN with_IN
        apoptosis_NNS and_CC how_WRB it_PRP might_MD be_VB coordinated_VBN with_IN cell_NN
        proliferation_NN in_IN a_DT large_JJ elastic_JJ artery_NN remain_VB unclear_JJ ._. The_DT
        present_JJ study_NN was_VBD aimed_VBN to_TO assess_VB gene_NN expression_NN of_IN both_DT
        TGF-β_NNP and_CC apoptosis_NNS related_VBD molecules_NNS in_IN early_JJ response_NN of_IN
        the_DT artery_NN to_TO an_DT increase_NN in_IN blood_NN flow_NN in_IN rat_NN abdominal_NN
        aorta_NN ._.
      
      
        Methods_NNP
        
          Animal_NNP model_NN of_IN aortocaval_NN fistula_NN
          The_DT aortocaval_NN fistula_NN (_( ACF_NNP )_) [_NN 18_CD 19_CD ]_NN was_VBD created_VBN
          between_IN the_DT infrarenal_NN abdominal_NN aorta_NN and_CC the_DT adjacent_JJ
          vena_NN cava_NN in_IN male_JJ Sprague-_NNP Dawley_NNP rats_NNS weighing_VBG 250_CD -_: 300_CD g_SYM ._.
          All_DT procedures_NNS were_VBD carried_VBN out_IN following_VBG the_DT guidelines_NNS
          set_VBN forth_RB in_IN the_DT 
          Resource_NNP Manual_NNP for_IN the_DT Care_NNP and_CC Use_NN of_IN
          Animals_NNS in_IN Research_NNP and_CC Teaching_NNP at_IN Stanford_NNP
          University_NNP ._. Surgical_NNP procedures_NNS were_VBD carried_VBN out_IN
          with_IN sterile_JJ technique_NN under_IN a_DT surgical_JJ microscope_NN ._. Rats_NNP
          were_VBD under_IN general_JJ anesthesia_NN with_IN an_DT intraperitoneal_NN
          injection_NN of_IN sodium_NN pentobarbital_NN (_( 50_CD mg_NN /_NN kg_NN )_) ._. Through_IN a_DT
          midline_NN abdominal_NN incision_NN the_DT infra-renal_JJ abdominal_NN
          aorta_NN and_CC the_DT inferior_JJ vena_NN cava_NN were_VBD visualized_JJ ._. The_DT
          aortic_JJ blood_NN flow_NN was_VBD stopped_VBN by_IN a_DT microvascular_NN clamp_NN
          placed_VBN 5_CD mm_NN above_IN the_DT iliac_NN bifurcation_NN ._. A_DT side-to-side_JJ
          ACF_NNP was_VBD constructed_VBN by_IN a_DT needle_NN puncture_NN method_NN using_VBG a_DT
          19_CD -_: guage_NN needle_NN ._. The_DT outer_JJ wall_NN of_IN the_DT aorta_NN distal_NN to_TO
          the_DT clamp_NN was_VBD pierced_JJ with_IN the_DT needle_NN ,_, which_WDT was_VBD then_RB
          advanced_VBN into_IN the_DT vena_NN cava_NN ._. The_DT needle_NN was_VBD subsequently_RB
          retrieved_VBN and_CC the_DT arteriotomy_NN was_VBD closed_VBN with_IN 8_CD -_: 0_CD silk_NN
          suture_NN ._. The_DT clamp_NN was_VBD then_RB removed_VBN and_CC the_DT vena_NN cava_NN was_VBD
          evaluated_VBN for_IN bright_JJ red_JJ color_NN ,_, an_DT indication_NN of_IN a_DT
          successful_JJ ACF_NNP ._. The_DT abdominal_NN wall_NN was_VBD closed_VBN with_IN silk_NN
          suture_NN ._. The_DT skin_NN was_VBD then_RB closed_VBN with_IN microsurgical_JJ
          clips_NNS ._. Sham_NNP operated_VBD rats_NNS underwent_VBD the_DT same_JJ surgical_JJ
          procedure_NN except_IN that_IN only_RB the_DT aortic_JJ wall_NN was_VBD pierced_JJ
          and_CC subsequently_RB closed_VBD without_IN ACF_NNP construction_NN ._.
        
        
          Time_NN course_NN of_IN study_NN
          Animals_NNS were_VBD sacrificed_JJ 1_CD and_CC 3_CD days_NNS ,_, 1_CD ,_, 2_CD ,_, 4_CD ,_, and_CC 8_CD
          weeks_NNS after_IN surgery_NN (_( n_NN =_SYM 3_CD for_IN each_DT time_NN point_NN )_) ._. Equal_NNP
          number_NN of_IN sham_NN operated_VBN and_CC age_NN matched_VBD animals_NNS served_VBD as_IN
          controls_NNS ._. Two_CD sets_NNS of_IN animals_NNS were_VBD used_VBN ._. One_CD was_VBD for_IN
          extraction_NN of_IN total_JJ tissue_NN RNA_NNP and_CC protein_NN and_CC one_CD for_IN
          perfusion_NN fixation_NN for_IN histology_NN ._.
        
        
          Blood_NNP flow_NN measurement_NN and_CC wall_NN shear_NN stress_NN
          calculations_NNS
          Blood_NNP flow_NN rate_NN (_( mL_NN /_NN min_NN )_) in_IN the_DT infra-renal_JJ aorta_NN was_VBD
          measured_VBN by_IN micro_JJ Doppler_NNP velocimetry_NN before_IN and_CC
          immediately_RB after_IN ACF_NNP construction_NN and_CC again_RB at_IN the_DT end_NN
          of_IN the_DT experiment_NN ._. Wall_NNP shear_NN stress_NN (_( WSS_NNP )_) was_VBD calculated_VBN
          using_VBG the_DT Hagen-_NNP Poiseuille_NNP formula_NN τ_NN 
          W_NNP =_SYM 0_CD ._. 1_CD ×_NN 4_CD μQ_NN /_NN πr_NN 3_CD ,_, where_WRB τ_NN 
          W_NNP is_VBZ WSS_NNP in_IN newtons_NNS per_IN square_JJ meter_NN
          (_( Pa_NNP )_) ,_, μ_NN is_VBZ the_DT blood_NN viscosity_NN (_( 0_CD ._. 03_CD poise_NN )_) ,_, Q_NNP is_VBZ blood_NN
          flow_NN rate_NN (_( mL_NN /_NN s_VBZ )_) ,_, and_CC r_LS is_VBZ arterial_NN lumen_NN radius_JJ
          (_( centimeter_NN )_) [_NN 2_CD ]_NN ._.
        
        
          Sampling_NNP and_CC perfusion_NN fixation_NN
          The_DT infra-renal_JJ aorta_NN of_IN 5_CD mm_NN long_JJ ,_, starting_VBG 2_CD mm_NN
          proximal_NN to_TO the_DT fistula_NN ,_, was_VBD harvested_VBN and_CC immediately_RB
          frozen_VBN in_IN liquid_JJ nitrogen_NN for_IN extraction_NN of_IN total_JJ RNA_NNP and_CC
          protein_NN by_IN using_VBG Trizol_NNP Reagent_NNP (_( Life_NNP Technologies_NNPS ,_, Inc_NNP ._.
          Rockville_NNP ,_, MD_NNP )_) ._. For_IN histological_JJ study_NN the_DT animals_NNS were_VBD
          perfusion_NN fixed_VBN through_IN a_DT catheter_NN in_IN the_DT left_NN ventricle_NN
          of_IN the_DT heart_NN with_IN 4_CD %_NN paraformaldehyde_NN at_IN room_NN temperature_NN
          and_CC at_IN a_DT pressure_NN of_IN 100_CD mmHg_NN for_IN 30_CD minutes_NNS ._. This_DT was_VBD
          performed_VBN in_IN an_DT attempt_NN to_TO preserve_VB the_DT physiological_JJ
          architecture_NN of_IN the_DT vessel_NN wall_NN and_CC to_TO prevent_VB the_DT vessel_NN
          from_IN collapsing_VBG as_IN described_VBN previously_RB [_NN 6_CD ]_NN ._. The_DT aorta_NN
          was_VBD then_RB taken_VBN and_CC further_RBR fixed_VBN in_IN 4_CD %_NN paraformaldehyde_NN
          for_IN two_CD more_JJR hours_NNS ._. The_DT standard_JJ site_NN for_IN sectioning_VBG was_VBD
          at_IN 4_CD mm_NN proximal_NN to_TO the_DT fistula_NN orifice_NN ,_, which_WDT is_VBZ
          equivalent_JJ to_TO the_DT middle_JJ portion_NN of_IN the_DT samples_NNS for_IN total_JJ
          RNA_NNP extraction_NN ._. Paraffin_NNP embedded_VBN and_CC frozen_VBN sections_NNS
          were_VBD prepared_VBN as_IN needed_VBN ._.
        
        
          Ribonuclease_NNP protection_NN assay_NN
          Relative_NNP mRNA_NN levels_NNS were_VBD assessed_VBN using_VBG ribonuclease_NN
          protection_NN assay_NN (_( RPA_NNP )_) to_TO determine_VB gene_NN expression_NN of_IN
          growth_NN factors_NNS and_CC apoptosis_NNS related_VBD molecules_NNS ._.
          Non-radioactive_NNP RNA_NNP probes_NNS were_VBD transcribed_JJ from_IN
          multi-probe_JJ template_NN set_VBN for_IN rat_NN cytokines_NNS (_( rCK-_NN 3_LS )_) and_CC a_DT
          set_VBN for_IN rat_NN apoptosis_NNS factors_NNS (_( rAPO-_NN 1_LS )_) ,_, (_( Pharmingen_NNP ,_, San_NNP
          Diego_NNP ,_, CA_NNP )_) [_NN 6_CD ]_NN ._. An_DT in_IN vitro_NN RNA_NNP transcription_NN kit_NN
          (_( Promega_NNP ,_, Madison_NNP ,_, WS_NNP )_) was_VBD applied_VBN with_IN the_DT addition_NN of_IN
          biotin-_NN 16_CD -_: UTP_NNP for_IN labeling_VBG the_DT probes_NNS (_( Roche_NNP ,_,
          Indianapolis_NNP ,_, IN_IN )_) ._. The_DT sensitivity_NN and_CC specificity_NN of_IN the_DT
          probes_NNS were_VBD carefully_RB tested_VBN before_IN starting_VBG the_DT
          experiment_NN ._. Five_CD micrograms_NNS of_IN total_JJ RNA_NNP from_IN each_DT animal_NN
          were_VBD hybridized_JJ with_IN the_DT probes_NNS and_CC an_DT RPA-III_NNP kit_NN
          (_( Ambion_NNP ,_, Austin_NNP ,_, TX_NNP )_) was_VBD used_VBN for_IN RPA_NNP following_VBG the_DT
          manufacturer_NN 's_POS protocols_NNS ._. The_DT protected_VBN fragments_NNS of_IN the_DT
          probes_NNS were_VBD resolved_VBN in_IN 5_CD %_NN denaturing_VBG polyacrylamide_NN gel_NN
          followed_VBN by_IN blotting_VBG to_TO a_DT positively-charged_JJ nylon_NN
          membrane_NN ._. The_DT resolved_VBN probes_NNS were_VBD detected_VBN using_VBG
          BrightStar_NNP kit_NN (_( Ambion_NNP )_) and_CC exposed_VBN to_TO films_NNS ._. The_DT
          resulted_VBD films_NNS were_VBD scanned_JJ ,_, and_CC densitometry_NN was_VBD
          performed_VBN with_IN NIH_NNP Image_NN program_NN version_NN 1_CD ._. 62_CD (_( National_NNP
          Institutes_NNPS of_IN Health_NNP ,_, Bethesda_NNP ,_, MD_NNP )_) ._. The_DT relative_JJ values_NNS
          of_IN protected_VBN probe_NN fragments_NNS were_VBD expressed_VBN as_IN a_DT ratio_NN of_IN
          their_PRP$ densitometry_NN values_NNS over_IN those_DT of_IN GAPDH_NNP
          (_( glyceraldehyde-_NN 3_CD -_: phosphate_NN dehydrogenase_NN )_) in_IN the_DT same_JJ
          lane_NN ._. The_DT mean_NN and_CC SD_NNP were_VBD calculated_VBN for_IN each_DT time_NN
          point_NN ._.
        
        
          Western_JJ blot_NN analysis_NN and_CC
          immunohistochemistry_NN
          Western_NNP blotting_VBG analysis_NN was_VBD performed_VBN for_IN analyses_NNS
          of_IN TGF-β_NNP 1_CD and_CC β_NN 3_CD as_RB well_RB as_IN Bcl-x_NNP S_NNP ._. All_DT procedures_NNS were_VBD
          published_VBN previously_RB [_NN 6_CD 20_CD ]_NN ._. In_IN brief_JJ ,_, protein_NN samples_NNS
          of_IN 25_CD μg_NN in_IN 2_CD ×_NN sodium_NN dodecylsulfate_NN loading_NN buffer_NN were_VBD
          fractionated_JJ by_IN 10_CD %_NN sodium_NN dodecylsulfate-polyacrylamide_JJ
          gel_NN electrophoresis_NNS at_IN 100_CD V_NNP ._. The_DT proteins_NNS were_VBD
          transferred_VBN onto_IN 0_CD ._. 45_CD -_: μm_NN pore_NN nitrocellulose_NN membrane_NN
          (_( Schleicher_NNP &_CC Schuell_NNP ,_, Keene_NNP ,_, NH_NNP )_) at_IN 40_CD V_NNP for_IN 45_CD to_TO
          60_CD minutes_NNS ._. The_DT membranes_NNS were_VBD blocked_VBN with_IN 5_CD %_NN nonfat_JJ
          milk_NN and_CC incubated_JJ at_IN room_NN temperature_NN for_IN 1_CD hour_NN with_IN
          anti-_NN TGF-β_NNP 1_CD polyclonal_NN antibody_NN at_IN a_DT 1_CD :_: 200_CD dilution_NN ,_,
          anti-_NN TGF-β_NNP 3_CD polyclonal_NN antibody_NN at_IN a_DT 1_CD :_: 1000_CD dilution_NN ,_, and_CC
          anti_NN Bcl-x_NNP S_NNP polyclonal_NN antibody_NN at_IN 1_CD :_: 500_CD dilution_NN ._. After_IN
          extensive_JJ washes_NNS with_IN phosphate_NN buffered_JJ saline_NN ,_, the_DT
          blots_NNS were_VBD incubated_JJ with_IN appropriate_JJ secondary_JJ
          antibodies_NNS (_( 1_CD :_: 1000_CD )_) conjugated_JJ with_IN horseradish_NN
          peroxidase_NN for_IN 1_CD hour_NN at_IN room_NN temperature_NN ._. The_DT blots_NNS were_VBD
          washed_VBN three_CD times_NNS in_IN phosphate-buffered_JJ saline_NN ,_, and_CC the_DT
          protein_NN complexes_NNS were_VBD detected_VBN with_IN enhanced_JJ
          chemiluminescence_NN detection_NN reagents_NNS according_VBG to_TO the_DT
          manufacturer_NN 's_POS protocol_NN (_( Amersham_NNP Pharmacia_NNP Biotech_NNP ,_, Inc_NNP ,_,
          Piscataway_NNP ,_, NJ_NNP )_) ._. The_DT presented_VBN data_NN are_VBP the_DT results_NNS from_IN
          three_CD animals_NNS in_IN each_DT of_IN the_DT time_NN points_NNS ._. Protein_NNP samples_NNS
          from_IN each_DT animal_NN were_VBD fractionated_JJ on_IN more_JJR than_IN one_CD gel_NN ,_,
          in_IN duplicate_VB or_CC triplicate_NN ._.
          Immunohistochemistry_NNP was_VBD performed_VBN on_IN paraffin_NN
          sections_NNS ,_, 4_CD micron_NN in_IN thickness_NN ,_, following_VBG previous_JJ
          protocols_NNS [_NN 5_CD ]_NN ._. The_DT same_JJ antibodies_NNS used_VBN for_IN western_JJ
          blotting_VBG were_VBD used_VBN for_IN detection_NN of_IN TGF-β_NNP 1_CD and_CC TGF-β_NNP 3_CD
          with_IN optimized_JJ dilutions_NNS ._. Sections_NNP were_VBD de-paraffinized_JJ
          and_CC rehydrated_JJ in_IN PBS_NNP ,_, followed_VBN by_IN incubation_NN in_IN 3_CD %_NN H_NNP 
          2_CD O_NNP 
          2_CD in_IN PBS_NNP for_IN 10_CD minutes_NNS ._. After_IN washes_NNS
          in_IN PBS_NNP for_IN 5_CD minutes_NNS ,_, the_DT sections_NNS were_VBD incubated_JJ in_IN
          1_CD :_: 100_CD diluted_VBN horse_NN serum_NN for_IN 30_CD minutes_NNS ._. Sections_NNP were_VBD
          incubated_JJ with_IN primary_JJ antibody_NN at_IN 1_CD :_: 50_CD dilution_NN in_IN PBS_NNP
          for_IN 1_CD hour_NN at_IN room_NN temperature_NN ._. After_IN 3_CD washes_NNS in_IN PBS_NNP ,_,
          the_DT sections_NNS were_VBD incubated_JJ with_IN the_DT corresponding_JJ
          biotinylated_JJ secondary_JJ antibody_NN (_( Vector_NNP Laboratories_NNPS ,_,
          Inc_NNP ,_, CA_NNP )_) at_IN 1_CD :_: 200_CD dilutions_NNS for_IN 1_CD hour_NN at_IN room_NN
          temperature_NN followed_VBN by_IN ABC-DAB_NNP method_NN (_( Vector_NNP
          Laboratories_NNPS ,_, Inc_NNP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS
          protocol_NN ._. The_DT detection_NN was_VBD brown_JJ precipitates_NNS as_IN a_DT
          result_NN of_IN the_DT reaction_NN of_IN DAB_NNP with_IN horse_NN radish_NN
          peroxidase_NN ._. The_DT sections_NNS were_VBD counterstained_JJ with_IN
          hematoxylin_NN and_CC coverslipped_JJ ._.
        
        
          Cell_NNP proliferation_NN evaluation_NN and_CC apoptosis_NNS
          detection_NN
          Incorporation_NNP and_CC detection_NN technique_NN [_NN 6_CD ]_NN of_IN
          5_CD -_: bromo-_NN 2_CD '_POS -_: deoxy-uridine_JJ (_( BrdU_NNP )_) was_VBD used_VBN to_TO assess_VB DNA_NNP
          synthesis_NN during_IN cell_NN proliferation_NN ._. Three_CD injections_NNS of_IN
          BrdU_NNP (_( Sigma_NNP ,_, St_NNP Louis_NNP ,_, Mo_NNP )_) ,_, 50_CD mg_NN /_NN kg_NN body_NN weight_NN ,_, were_VBD
          administered_VBN intraperitoneally_RB to_TO the_DT animals_NNS 20_CD ,_, 6_CD ,_, and_CC
          1_CD hours_NNS before_IN they_PRP were_VBD humanely_RB killed_VBN ._. Immunodetection_NNP
          of_IN BrdU_NNP incorporation_NN was_VBD performed_VBN on_IN frozen_VBN sections_NNS
          with_IN a_DT detection_NN kit_NN (_( Roche_NNP )_) ._. The_DT cell_NN type_NN of_IN
          BrdU-incorporated_NNP cells_NNS was_VBD assessed_VBN histologically_RB ._. In_IN
          addition_NN ,_, an_DT antibody_NN against_IN α-actin_JJ (_( Enzo_NNP Diagnostics_NNPS ,_,
          Inc_NNP ,_, Farmingdale_NNP ,_, NY_NNP )_) was_VBD used_VBN to_TO confirm_VB SMCs_NNP in_IN the_DT
          media_NNS ._. The_DT number_NN of_IN BrdU-labeled_NNP nuclei_NN was_VBD counted_VBN from_IN
          each_DT whole_JJ cross_NN section_NN ._. The_DT mean_NN and_CC SD_NNP were_VBD obtained_VBN
          from_IN three_CD animals_NNS for_IN each_DT time_NN interval_NN ,_, and_CC the_DT cell_NN
          proliferation_NN rate_NN was_VBD expressed_VBN as_IN a_DT number_NN of_IN labeled_VBN
          nuclei_NN per_IN section_NN ._. Terminal_NNP deoxynucleotidyl_NN
          transferase-mediated_JJ dUTP_NN nick_NN end-labeling_JJ (_( TUNEL_NNP )_)
          method_NN was_VBD used_VBN to_TO demonstrate_VB apoptosis_NNS in_IN SMCs_NNP and_CC
          endothelial_NN cells_NNS [_NN 6_CD ]_NN ._. The_DT TUNEL_NNP was_VBD performed_VBN on_IN
          frozen_VBN sections_NNS ._. An_DT in_IN situ_NN cell_NN death_NN detection_NN kit_NN
          (_( Roche_NNP )_) was_VBD used_VBN for_IN TUNEL_NNP with_IN modifications_NNS ._. Nuclei_NNP of_IN
          apoptotic_JJ cells_NNS were_VBD thus_RB labeled_VBN with_IN fluorescein_NN ,_, and_CC
          the_DT sections_NNS were_VBD counterstained_JJ with_IN propidium_NN iodide_NN
          and_CC observed_VBD under_IN laser-scanning_JJ confocal_NN microscope_NN
          (_( Bio-_NNP Rad_NNP MRC_NNP 1024_CD ,_, Hercules_NNP ,_, CA_NNP )_) ._. Negative_JJ controls_NNS were_VBD
          included_VBN by_IN omitting_VBG the_DT labeling_VBG buffer_NN ._. Positive_JJ
          controls_NNS were_VBD obtained_VBN by_IN digestion_NN of_IN the_DT sections_NNS with_IN
          deoxyribonuclease_NN I_PRP for_IN 10_CD minutes_NNS at_IN room_NN temperature_NN
          before_IN the_DT detection_NN procedure_NN ._. Labeled_NNP nuclei_NN were_VBD
          counted_VBN per_IN section_NN ._. The_DT mean_NN and_CC SD_NNP of_IN each_DT time_NN point_NN
          were_VBD obtained_VBN from_IN three_CD animals_NNS for_IN statistical_JJ
          analysis_NN ._.
        
        
          Histology_NNP and_CC morphometry_NN
          Cross_NNP sections_NNS from_IN the_DT perfusion_NN fixed_VBD specimens_NNS were_VBD
          stained_JJ with_IN H_NNP ._. E_NNP ._. and_CC Mason_NNP 's_POS trichrome_NN staining_VBG ._. The_DT
          sections_NNS were_VBD digitized_JJ by_IN tracing_VBG the_DT contours_NNS of_IN the_DT
          lumen_NN ,_, the_DT internal_JJ elastic_JJ lamella_NN ,_, and_CC the_DT external_JJ
          elastic_JJ lamella_NN ._. The_DT lumen_NN diameter_NN was_VBD calculated_VBN from_IN
          the_DT circumference_NN of_IN the_DT lumen_NN ._. The_DT external_JJ diameter_NN was_VBD
          calculated_VBN from_IN the_DT circumference_NN of_IN the_DT external_JJ elastic_JJ
          lamella_NN ._. The_DT average_JJ wall_NN thickness_NN was_VBD the_DT difference_NN of_IN
          the_DT two_CD diameters_NNS divided_VBN by_IN 2_CD ._. Mean_VB and_CC SD_NNP were_VBD
          calculated_VBN from_IN 3_CD sections_NNS of_IN each_DT time_NN point_NN ._.
        
        
          Statistical_NNP analysis_NN
          Data_NNP were_VBD presented_VBN as_IN mean_NN ±_NN SD_NNP ._. Single_NNP factor_NN
          analysis_NN of_IN variance_NN (_( ANOVA_NNP )_) and_CC Bonferroni_NNP 's_POS test_NN were_VBD
          used_VBN for_IN multiple-comparisons_JJ ._. StatView_NNP software_NN version_NN
          5_CD ._. 0_CD (_( SAS_NNP Institute_NNP Inc_NNP ,_, San_NNP Francisco_NNP ,_, CA_NNP )_) was_VBD used_VBN for_IN
          the_DT statistical_JJ analysis_NN ._. The_DT difference_NN was_VBD considered_VBN
          significant_JJ if_IN P_NN <_NN 0_CD ._. 05_CD ._.
        
      
      
        Results_NNS
        
          Blood_NNP flow_NN ,_, wall_NN shear_NN stress_NN ,_, lumen_NN diameter_NN ,_, and_CC
          wall_NN thickness_NN
          The_DT ACF_NNP produced_VBD an_DT increase_NN in_IN blood_NN flow_NN and_CC
          therefore_RB WSS_NNP in_IN the_DT infrarenal_NN aorta_NN by_IN more_JJR than_IN 5_CD
          folds_NNS after_IN surgery_NN (_( Table_NNP 1_LS )_) ._. Morphometry_NNP revealed_VBD an_DT
          increase_NN in_IN lumen_NN diameters_NNS ._. The_DT lumen_NN diameter_NN started_VBD
          to_TO increase_VB at_IN 1_CD week_NN after_IN ACF_NNP although_IN this_DT change_NN did_VBD
          not_RB reach_VB statistical_JJ significance_NN ._. At_IN 2_CD weeks_NNS and_CC
          thereafter_RB ,_, the_DT lumen_NN diameters_NNS were_VBD significantly_RB larger_JJR
          than_IN those_DT of_IN controls_NNS ,_, which_WDT were_VBD accompanied_VBN with_IN
          decreased_VBD wall_NN thickness_NN (_( Figure_NN 1_CD and_CC table_NN 1_LS )_) ._.
        
        
          Expression_NNP of_IN cell_NN growth_NN related_VBD cytokines_NNS
          RPA_NNP using_VBG the_DT multiple_JJ probes_NNS of_IN rCK-_NN 3_CD revealed_VBD an_DT
          upregulation_NN of_IN both_DT TGF-β_NNP 1_CD and_CC TGF-β_NNP 3_CD gene_NN expression_NN ._.
          The_DT relative_JJ mRNA_NN levels_NNS of_IN them_PRP increased_VBD with_IN a_DT peak_NN at_IN
          3_CD days_NNS ._. The_DT levels_NNS declined_VBD after_IN 3_CD days_NNS and_CC returned_VBD to_TO
          control_VB levels_NNS (_( Figure_NN 2_CD ,_, left_VBD panels_NNS )_) ._. Western_JJ blot_NN
          analysis_NN showed_VBD an_DT increase_NN in_IN the_DT protein_NN levels_NNS with_IN a_DT
          similar_JJ trend_NN to_TO mRNA_NN levels_NNS for_IN both_DT TGF-β_NNP 1_CD and_CC β_NN 3_CD
          (_( Figure_NN 2_CD ,_, right_JJ panels_NNS )_) ._. Moreover_RB ,_, TGF-β_NNP 3_CD protein_NN levels_NNS
          remained_VBD high_JJ at_IN 1_CD week_NN ._. These_DT changes_NNS preceded_VBN the_DT
          aortic_JJ enlargement_NN ,_, which_WDT happened_VBD at_IN 2_CD weeks_NNS ._.
          Immunohistochemistry_NNP revealed_VBD detection_NN of_IN both_DT TGF-β_NNP 1_CD
          and_CC β_NN 3_CD after_IN flow_NN increased_VBD ._. The_DT increased_VBN expression_NN
          peaked_VBD at_IN 1_CD and_CC 3_CD days_NNS compared_VBN to_TO controls_NNS ._. The_DT
          expression_NN of_IN these_DT growth_NN factors_NNS was_VBD closely_RB associated_VBN
          with_IN immunohistochemical_JJ staining_VBG (_( Figure_NN 3_LS )_) ._. The_DT SMC_NNP in_IN
          the_DT inner_JJ and_CC outer_JJ zones_NNS of_IN the_DT media_NNS seemed_VBD to_TO be_VB more_RBR
          involved_JJ in_IN the_DT expression_NN of_IN these_DT growth_NN factors_NNS ._.
        
        
          Expression_NNP of_IN apoptosis-related_JJ molecules_NNS
          RPA_NNP with_IN the_DT multiple-probe_JJ of_IN rAPO-_NN 1_CD showed_VBD that_IN
          relative_JJ mRNA_NN levels_NNS of_IN Bcl-x_NNP short_JJ isoform_NN (_( Bcl-x_NNP S_NNP )_) ,_,
          known_VBN as_IN pro-apoptotic_JJ factors_NNS ,_, initially_RB decreased_VBD at_IN 1_CD
          day_NN ,_, 3_CD days_NNS and_CC 1_CD week_NN followed_VBN by_IN returning_VBG to_TO base_VB line_NN
          level_NN after_IN 2_CD W_NNP (_( Figure_NN 4_LS )_) ._. There_EX was_VBD an_DT increase_NN in_IN
          caspase-_NN 3_CD and_CC Bax_NNP mRNA_NN levels_NNS at_IN 4_CD W_NNP ._. Other_JJ factors_NNS did_VBD
          not_RB show_VB significant_JJ changes_NNS ._. Western_NNP blotting_VBG analysis_NN
          showed_VBD a_DT similar_JJ trend_NN of_IN mRNA_NN level_NN for_IN Bcl-x_NNP S_NNP (_( Figure_NN
          4_LS )_) ,_, but_CC statistical_JJ outcome_NN did_VBD not_RB reach_VB significance_NN ._.
          Immunohistochemistry_NNP did_VBD not_RB show_VB any_DT apparent_JJ detection_NN
          of_IN these_DT molecules_NNS ._.
        
        
          Cell_NNP proliferation_NN
          Cell_NNP proliferation_NN was_VBD remarkable_JJ for_IN both_DT EC_NNP and_CC SMC_NNP
          with_IN EC_NNP more_RBR significant_JJ than_IN SMC_NNP (_( Figure_NN 5_LS )_) ._. BrdU_NNP
          incorporated_VBD nuclei_NN were_VBD observed_VBN in_IN the_DT media_NNS ,_, along_IN the_DT
          endothelial_NN line_NN and_CC in_IN the_DT adventitia_NN ._. The_DT incorporation_NN
          rate_NN for_IN endothelial_NN cells_NNS increased_VBN at_IN 1_CD week_NN and_CC
          thereafter_RB (_( P_NN <_NN 0_CD ._. 05_CD vs_NNS ._. controls_NNS )_) and_CC the_DT
          incorporation_NN rate_NN of_IN SMC_NNP increased_VBD at_IN 4_CD weeks_NNS (_( P_NN <_NN
          0_CD ._. 05_CD vs_NNS ._. controls_NNS )_) (_( Table_NNP 1_LS )_) ._.
        
        
          Cell_NNP apoptosis_NNS
          Apoptosis_NNP of_IN vascular_NN cells_NNS was_VBD assessed_VBN by_IN TUNEL_NNP
          method_NN in_IN all_DT animals_NNS ._. There_EX was_VBD no_DT remarkable_JJ difference_NN
          in_IN apoptosis_NNS rate_NN after_IN ACF_NNP creation_NN (_( data_NNS not_RB
          shown_VBN )_) ._.
        
      
      
        Discussion_NNP
        Vascular_NNP wall_NN remodeling_VBG in_IN response_NN to_TO hemodynamic_JJ
        alterations_NNS has_VBZ been_VBN known_VBN closely_RB related_VBN to_TO lesion_NN
        development_NN in_IN the_DT arterial_NN wall_NN [_NN 21_CD 22_CD 23_CD ]_NN ._. Arterial_NNP
        wall_NN shear_NN stress_NN is_VBZ proven_VBN to_TO be_VB a_DT critical_JJ factor_NN in_IN
        regulation_NN of_IN vessel_NN diameter_NN ._. Increase_VB in_IN blood_NN flow_NN ,_, or_CC
        shear_NN stress_NN ,_, induces_VBZ enlargement_NN of_IN the_DT artery_NN [_NN 2_CD 24_CD 25_CD
        26_CD ]_NN ;_: and_CC decrease_VB in_IN shear_NN stress_NN results_NNS in_IN reduction_NN of_IN
        lumen_NN diameter_NN of_IN the_DT artery_NN [_NN 26_CD 27_CD 28_CD ]_NN ._.
        The_DT present_JJ study_NN once_RB again_RB demonstrated_VBN that_WDT increased_VBD
        blood_NN flow_NN rate_NN induced_VBD arterial_NN enlargement_NN in_IN an_DT
        aortocaval_NN fistula_NN model_NN in_IN rats_NNS ._. More_RBR significantly_RB ,_, this_DT
        model_NN subjects_VBZ the_DT abdominal_NN aortic_JJ aorta_NN to_TO a_DT condition_NN of_IN
        an_DT acute_JJ increase_NN in_IN blood_NN flow_NN ._. So_RB far_RB ,_, most_JJS of_IN vessel_NN
        remodeling_VBG studies_NNS are_VBP based_VBN on_IN peripheral_JJ arteries_NNS ,_, such_JJ
        as_IN carotid_NN and_CC iliac_NN arteries_NNS ._. There_EX are_VBP very_RB few_JJ models_NNS
        using_VBG larger_JJR and_CC elastic_JJ arteries_NNS like_IN aorta_NN for_IN study_NN of_IN
        flow-induced_JJ response_NN [_NN 19_CD ]_NN ._. The_DT current_JJ model_NN provides_VBZ a_DT
        direct_JJ access_NN to_TO the_DT investigation_NN of_IN abdominal_NN aorta_NN with_IN
        blood_NN flow-induced_JJ hemodynamic_JJ alteration_NN ._.
        The_DT study_NN showed_VBD that_IN the_DT adaptive_JJ enlargement_NN was_VBD
        associated_VBN with_IN increased_VBN gene_NN expression_NN of_IN TGF-β_NNP 1_CD and_CC β_NN 3_CD ,_,
        known_VBN as_IN tissue_NN remodeling_VBG mediators_NNS [_NN 12_CD 17_CD 29_CD ]_NN ._. Gene_NNP
        expression_NN of_IN TGF-β_NNP 1_CD and_CC β_NN 3_CD was_VBD upregulated_JJ at_IN 1_CD and_CC 3_CD days_NNS
        and_CC 1_CD week_NN upon_IN increase_NN in_IN blood_NN flow_NN ,_, while_IN the_DT
        flow-induced_JJ aortic_JJ enlargement_NN occurred_VBD 2_CD weeks_NNS after_IN ACF_NNP
        creation_NN ._. Furthermore_RB ,_, the_DT expression_NN of_IN these_DT growth_NN
        factors_NNS mainly_RB associated_VBN with_IN endothelial_NN cells_NNS and_CC smooth_JJ
        muscle_NN cells_NNS in_IN the_DT inner_JJ media_NNS ._. These_DT results_NNS suggest_VBP that_IN
        the_DT function_NN of_IN TGF-β_NNP superfamily_RB may_MD be_VB a_DT prerequisite_NN for_IN
        the_DT arterial_NN dilatation_NN and_CC that_IN endothelial_NN cells_NNS and_CC the_DT
        smooth_JJ muscle_NN cells_NNS may_MD be_VB responsible_JJ for_IN the_DT forth-going_JJ
        vessel_NN enlargement_NN ._.
        TGF-β_NNP expression_NN is_VBZ closely_RB associated_VBN with_IN an_DT increase_NN
        in_IN wall_NN shear_NN stress_NN [_NN 30_CD 31_CD ]_NN and_CC with_IN different_JJ forms_NNS of_IN
        fluid_JJ shear_NN stress_NN [_NN 32_CD ]_NN ,_, and_CC its_PRP$ function_NN is_VBZ modulated_JJ
        by_IN variety_NN of_IN factors_NNS [_NN 14_CD ]_NN ._. For_IN example_NN ,_, TGF-β_NNP 1_CD is_VBZ
        secreted_JJ in_IN an_DT inactive_JJ precursor_NN and_CC requires_VBZ
        furin-mediated_JJ maturation_NN [_NN 33_CD ]_NN ._. TGF-β_NNP 1_CD in_IN turn_NN induces_VBZ
        expression_NN of_IN furin_NN ._. It_PRP has_VBZ been_VBN demonstrated_VBN that_IN both_DT
        furin_NN and_CC TGF-β_NNP gene_NN expression_NN was_VBD upregulated_JJ by_IN fluid_JJ
        shear_NN stress_NN in_IN vascular_NN endothelial_NN cells_NNS ._. Thus_RB ,_, the_DT
        positive_JJ feedback_NN may_MD enhance_VB the_DT effect_NN of_IN TGF-β_NNP 1_CD on_IN
        endothelial_NN cells_NNS and_CC vascular_NN smooth_JJ muscle_NN cells_NNS as_IN
        demonstrated_VBN by_IN Negishi_NNP et_CC al_NN ._. [_NN 15_CD ]_NN ._. The_DT present_JJ study_NN
        demonstrated_VBN that_IN fluid_JJ shear_NN stress_NN induced_VBD regulation_NN of_IN
        TGF-β_NNP expression_NN in_IN the_DT larger_JJR elastic_JJ artery_NN ._. Furthermore_RB ,_,
        TGF-β_NNP upregulation_NN was_VBD associated_VBN with_IN cell_NN proliferation_NN ,_,
        which_WDT was_VBD significant_JJ at_IN almost_RB all_DT time_NN points_NNS ,_, with_IN EC_NNP
        more_RBR remarkable_JJ than_IN SMC_NNP ._. TGF-β_NNP superfamily_RB of_IN growth_NN
        factors_NNS is_VBZ powerful_JJ and_CC subtle_JJ regulation_NN of_IN its_PRP$ expression_NN
        may_MD exert_VB a_DT remarkable_JJ action_NN ._. TGF-β_NNP is_VBZ a_DT potent_JJ regulator_NN
        of_IN the_DT cell_NN cycle_NN in_IN many_JJ cell_NN types_NNS including_VBG vascular_NN
        smooth_JJ muscle_NN and_CC endothelial_NN cells_NNS ,_, and_CC as_IN a_DT result_NN this_DT
        growth_NN factor_NN has_VBZ been_VBN postulated_JJ to_TO play_VB an_DT important_JJ ,_,
        though_IN largely_RB undefined_JJ ,_, role_NN in_IN vascular_NN proliferative_JJ
        processes_VBZ [_NN 14_CD ]_NN ._. So_RB far_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT
        modulation_NN role_NN of_IN TGF-β_NNP 3_CD in_IN vessel_NN remodeling_NN ._. It_PRP is_VBZ known_VBN
        that_IN TGF-β_NNP 3_CD plays_VBZ a_DT role_NN in_IN cardiac_JJ morphogenesis_NNS ,_, mammary_JJ
        gland_NN development_NN and_CC wound_VBD healing_VBG and_CC that_IN TGF-β_NNP 3_CD is_VBZ
        involved_VBN in_IN fine-tuned_JJ interactions_NNS between_IN epithelial_NN and_CC
        mesenchymal_NN cells_NNS and_CC their_PRP$ products_NNS [_NN 34_CD ]_NN ._. The_DT exact_JJ
        role_NN of_IN TGF-β_NNP 3_CD in_IN vascular_NN remodeling_VBG response_NN remains_VBZ
        unclear_JJ ._. It_PRP is_VBZ conceivable_JJ that_IN after_IN an_DT acute_JJ regulation_NN
        of_IN cell_NN proliferation_NN and_CC ECM_NNP degradation_NN ,_, TGF-β_NNP 3_CD may_MD exert_VB
        a_DT fine_NN tune_NN up_RB between_IN cells_NNS and_CC ECM_NNP for_IN a_DT reconstruction_NN
        of_IN the_DT remodeled_VBN wall_NN ._.
        The_DT mechanical_JJ and_CC biochemical_JJ mechanisms_NNS of_IN flow_NN or_CC
        shear-regulated_JJ arterial_NN dilatation_NN and_CC the_DT vessel_NN
        remodeling_VBG have_VBP been_VBN widely_RB studied_VBN [_NN 35_CD ]_NN ._. Vessel_NNP wall_NN
        shear_NN stress_NN exerted_VBN by_IN blood_NN flow_NN is_VBZ a_DT regulating_VBG
        mechanical_JJ force_NN on_IN endothelial_NN cells_NNS that_WDT has_VBZ important_JJ
        physiological_JJ and_CC pathological_JJ cardiovascular_JJ consequences_NNS ._.
        The_DT endothelial_NN monolayer_NN in_IN vivo_NN acts_NNS as_IN a_DT signal_NN
        transduction_NN interface_NN for_IN mechanical_JJ forces_NNS ,_, in_IN
        particular_JJ ,_, shear_NN stress_NN ._. Mechanisms_NNPS related_VBD to_TO spatial_NN
        relationships_NNS at_IN the_DT cell_NN surfaces_VBZ and_CC throughout_IN the_DT cells_NNS
        in_IN the_DT wall_NN that_DT influence_NN flow-mediated_JJ endothelial_NN
        mechanotransduction_NN involve_VB many_JJ cytokines_NNS including_VBG TGF-β_NNP
        superfamily_RB ._. Furthermore_RB ,_, flow-mediated_JJ ion_NN channel_NN
        activation_NN and_CC cytoskeletal_NN dynamics_NNS are_VBP related_VBN to_TO
        topographic_JJ characteristics_NNS of_IN the_DT luminal_NN and_CC abluminal_NN
        surfaces_VBZ of_IN living_VBG endothelial_NN cells_NNS [_NN 35_CD ]_NN ._.
        Arterial_NNP dilatation_NN is_VBZ thought_VBN to_TO be_VB endothelial_NN
        dependent_JJ [_NN 26_CD 36_CD ]_NN ._. Endothelial_NNP proliferation_NN during_IN the_DT
        flow-induced_JJ arterial_NN enlargement_NN has_VBZ been_VBN shown_VBN to_TO be_VB a_DT
        characteristic_JJ event_NN [_NN 2_CD ]_NN ._. The_DT vessel_NN enlargement_NN results_NNS
        in_IN an_DT increase_NN in_IN lumen_NN surface_NN area_NN while_IN endothelial_NN cell_NN
        proliferation_NN assures_VBZ a_DT continuous_JJ cell_NN lining_NN
        throughout_IN ._.
        Our_PRP$ observation_NN indicated_VBD that_IN apoptosis_NNS was_VBD not_RB
        remarkable_JJ in_IN the_DT early_JJ stage_NN of_IN flow-induced_JJ dilatation_NN ;_:
        although_IN apoptosis_NNS has_VBZ been_VBN implicated_VBN to_TO play_VB a_DT role_NN in_IN
        vessel_NN remodeling_VBG [_NN 1_CD ]_NN ._. There_EX was_VBD little_JJ change_NN in_IN TUNNEL_NNP
        analysis_NN after_IN ACF_NNP creation_NN ._. However_RB ,_, some_DT
        apoptosis-related_JJ factors_NNS were_VBD regulated_VBN ._. For_IN example_NN ,_, the_DT
        mRNA_NN levels_NNS of_IN Bcl-x_NNP S_NNP were_VBD initially_RB decreased_VBN at_IN 1_CD day_NN ,_, 3_CD
        days_NNS and_CC 1_CD week_NN followed_VBN by_IN returning_VBG to_TO base_VB line_NN level_NN
        after_IN 2_CD weeks_NNS ._. There_EX was_VBD an_DT increase_NN in_IN caspase-_NN 3_CD and_CC Bax_NNP
        mRNA_NN levels_NNS at_IN 4_CD weeks_NNS ._. Follow_VB up_RB western_JJ blotting_VBG analysis_NN
        was_VBD unable_JJ to_TO determine_VB the_DT expression_NN trends_NNS ,_, suggesting_VBG
        that_IN cell_NN apoptosis_NNS regulation_NN in_IN vivo_NN may_MD be_VB too_RB subtle_JJ to_TO
        be_VB detected_VBN ._.
        Apoptosis_NNP related_VBD molecules_NNS ,_, such_JJ as_IN Bcl-x_NNP S_NNP ,_, Bax_NNP ,_, and_CC
        casepase-_NN 3_CD ,_, are_VBP known_VBN to_TO be_VB proapoptotic_JJ factors_NNS and_CC
        involved_VBN in_IN variety_NN of_IN vessel_NN remodeling_VBG processes_VBZ [_NN 37_CD 38_CD
        39_CD ]_NN ._. The_DT initial_JJ arrest_NN in_IN Bcl-x_NNP S_NNP gene_NN expression_NN may_MD
        momentarily_RB depress_VB apoptosis_NNS ._. It_PRP is_VBZ conceivable_JJ that_IN
        during_IN the_DT early_JJ stage_NN of_IN the_DT remodeling_NN ,_, cell_NN
        proliferation_NN is_VBZ the_DT dominant_JJ response_NN and_CC apoptosis_NNS may_MD be_VB
        somewhat_RB repressed_VBN to_TO favor_VB cell_NN survival_NN ._. This_DT is_VBZ
        contested_VBN by_IN the_DT little_JJ changes_NNS in_IN TUNEL_NNP detection_NN ._.
      
      
        Conclusions_NNP
        In_IN summary_NN ,_, the_DT experiments_NNS demonstrate_VBP that_DT gene_NN
        expression_NN of_IN TGF-β_NNP 1_CD and_CC β_NN 3_CD precedes_VBZ the_DT flow_NN induced_VBD
        arterial_NN enlargement_NN and_CC is_VBZ associated_VBN with_IN cell_NN
        proliferation_NN ._. Expression_NNP of_IN apoptosis-related_JJ molecules_NNS ,_,
        such_JJ as_IN Bcl-x_NNP S_NNP ,_, Bax_NNP ,_, and_CC caspase-_NN 3_CD ,_, seems_VBZ to_TO be_VB little_RB
        regulated_VBN in_IN the_DT early_JJ stage_NN of_IN this_DT vessel_NN remodeling_VBG
        process_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        CX_NNP designed_VBD the_DT experiment_NN ,_, directed_VBD all_DT studies_NNS ,_,
        performed_VBD statistical_JJ analysis_NN ,_, and_CC drafted_VBD the_DT manuscript_NN ._.
        SL_NNP carried_VBD out_RP ACF_NNP procedures_NNS ,_, performed_VBD RPA_NNP and_CC cell_NN
        proliferation_NN and_CC apoptosis_NNS analyses_NNS ._. CS_NNP participated_VBD in_IN
        the_DT molecular_JJ analyses_NNS and_CC performed_VBN western_JJ blotting_VBG ._. HM_NNP
        participated_VBD in_IN the_DT design_NN of_IN the_DT study_NN and_CC offered_VBN help_VB in_IN
        histological_JJ study_NN ._. CKZ_NNP conceived_VBD of_IN the_DT study_NN ,_, directed_VBN
        and_CC oversaw_VBD the_DT project_NN ,_, participated_VBD in_IN its_PRP$ design_NN ,_, and_CC
        reviewed_VBD the_DT manuscript_NN ._.
        All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
